Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression

Implication for breast cancer osteolytic bone metastases

Guojun D Bu, Wenyan Lu, Chia-Chen Liu, Katri Selander, Toshiyuki Yoneda, Christopher Hall, Evan T. Keller, Yonghe Li

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Most breast cancer metastases in bone form osteolytic lesions, but the mechanisms of tumor-induced bone resorption and destruction are not fully understood. Although it is well recognized that Wnt/β-catenin signaling is important for breast cancer tumorigenesis, the role of this pathway in breast cancer bone metastasis is unclear. Dickkopf1 (Dkk1) is a secreted Wnt/β-catenin antagonist. In the present study, we demonstrated that activation of Wnt/β-catenin signaling enhanced Dkk1 expression in breast cancer cells and that Dkk1 overexpression is a frequent event in breast cancer. We also found that human breast cancer cell lines that preferentially form osteolytic bone metastases exhibited increased levels of Wnt/β-catenin signaling and Dkk1 expression. Moreover, we showed that breast cancer cell-produced Dkk1 blocked Wnt3A-induced osteoblastic differentiation and osteoprotegerin (OPG) expression of osteoblast precursor C2C12 cells and that these effects could be neutralized by a specific anti-Dkk1 antibody. In addition, we found that breast cancer cell conditioned media were able to block Wnt3A-induced NF-kappaB ligand reduction in C2C12 cells. Finally, we demonstrated that conditioned media from breast cancer cells in which Dkk1 expression had been silenced via RNAi were unable to block Wnt3A-induced C2C12 osteoblastic differentiation and OPG expression. Taken together, these results suggest that breast cancer-produced Dkk1 may be an important mechanistic link between primary breast tumors and secondary osteolytic bone metastases.

Original languageEnglish (US)
Pages (from-to)1034-1042
Number of pages9
JournalInternational Journal of Cancer
Volume123
Issue number5
DOIs
StatePublished - Sep 1 2008
Externally publishedYes

Fingerprint

Osteoprotegerin
Bone Neoplasms
Osteoblasts
Breast Neoplasms
Neoplasm Metastasis
Catenins
Conditioned Culture Medium
Bone and Bones
NF-kappa B
Bone Resorption
RNA Interference
Anti-Idiotypic Antibodies
Carcinogenesis

Keywords

  • Bone metastasis
  • Dkk1
  • OPG
  • Osteoblast differentiation
  • Wnt signaling

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression : Implication for breast cancer osteolytic bone metastases. / Bu, Guojun D; Lu, Wenyan; Liu, Chia-Chen; Selander, Katri; Yoneda, Toshiyuki; Hall, Christopher; Keller, Evan T.; Li, Yonghe.

In: International Journal of Cancer, Vol. 123, No. 5, 01.09.2008, p. 1034-1042.

Research output: Contribution to journalArticle

Bu, Guojun D ; Lu, Wenyan ; Liu, Chia-Chen ; Selander, Katri ; Yoneda, Toshiyuki ; Hall, Christopher ; Keller, Evan T. ; Li, Yonghe. / Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression : Implication for breast cancer osteolytic bone metastases. In: International Journal of Cancer. 2008 ; Vol. 123, No. 5. pp. 1034-1042.
@article{306984f5d0274de488b3aea6342000f8,
title = "Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases",
abstract = "Most breast cancer metastases in bone form osteolytic lesions, but the mechanisms of tumor-induced bone resorption and destruction are not fully understood. Although it is well recognized that Wnt/β-catenin signaling is important for breast cancer tumorigenesis, the role of this pathway in breast cancer bone metastasis is unclear. Dickkopf1 (Dkk1) is a secreted Wnt/β-catenin antagonist. In the present study, we demonstrated that activation of Wnt/β-catenin signaling enhanced Dkk1 expression in breast cancer cells and that Dkk1 overexpression is a frequent event in breast cancer. We also found that human breast cancer cell lines that preferentially form osteolytic bone metastases exhibited increased levels of Wnt/β-catenin signaling and Dkk1 expression. Moreover, we showed that breast cancer cell-produced Dkk1 blocked Wnt3A-induced osteoblastic differentiation and osteoprotegerin (OPG) expression of osteoblast precursor C2C12 cells and that these effects could be neutralized by a specific anti-Dkk1 antibody. In addition, we found that breast cancer cell conditioned media were able to block Wnt3A-induced NF-kappaB ligand reduction in C2C12 cells. Finally, we demonstrated that conditioned media from breast cancer cells in which Dkk1 expression had been silenced via RNAi were unable to block Wnt3A-induced C2C12 osteoblastic differentiation and OPG expression. Taken together, these results suggest that breast cancer-produced Dkk1 may be an important mechanistic link between primary breast tumors and secondary osteolytic bone metastases.",
keywords = "Bone metastasis, Dkk1, OPG, Osteoblast differentiation, Wnt signaling",
author = "Bu, {Guojun D} and Wenyan Lu and Chia-Chen Liu and Katri Selander and Toshiyuki Yoneda and Christopher Hall and Keller, {Evan T.} and Yonghe Li",
year = "2008",
month = "9",
day = "1",
doi = "10.1002/ijc.23625",
language = "English (US)",
volume = "123",
pages = "1034--1042",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression

T2 - Implication for breast cancer osteolytic bone metastases

AU - Bu, Guojun D

AU - Lu, Wenyan

AU - Liu, Chia-Chen

AU - Selander, Katri

AU - Yoneda, Toshiyuki

AU - Hall, Christopher

AU - Keller, Evan T.

AU - Li, Yonghe

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Most breast cancer metastases in bone form osteolytic lesions, but the mechanisms of tumor-induced bone resorption and destruction are not fully understood. Although it is well recognized that Wnt/β-catenin signaling is important for breast cancer tumorigenesis, the role of this pathway in breast cancer bone metastasis is unclear. Dickkopf1 (Dkk1) is a secreted Wnt/β-catenin antagonist. In the present study, we demonstrated that activation of Wnt/β-catenin signaling enhanced Dkk1 expression in breast cancer cells and that Dkk1 overexpression is a frequent event in breast cancer. We also found that human breast cancer cell lines that preferentially form osteolytic bone metastases exhibited increased levels of Wnt/β-catenin signaling and Dkk1 expression. Moreover, we showed that breast cancer cell-produced Dkk1 blocked Wnt3A-induced osteoblastic differentiation and osteoprotegerin (OPG) expression of osteoblast precursor C2C12 cells and that these effects could be neutralized by a specific anti-Dkk1 antibody. In addition, we found that breast cancer cell conditioned media were able to block Wnt3A-induced NF-kappaB ligand reduction in C2C12 cells. Finally, we demonstrated that conditioned media from breast cancer cells in which Dkk1 expression had been silenced via RNAi were unable to block Wnt3A-induced C2C12 osteoblastic differentiation and OPG expression. Taken together, these results suggest that breast cancer-produced Dkk1 may be an important mechanistic link between primary breast tumors and secondary osteolytic bone metastases.

AB - Most breast cancer metastases in bone form osteolytic lesions, but the mechanisms of tumor-induced bone resorption and destruction are not fully understood. Although it is well recognized that Wnt/β-catenin signaling is important for breast cancer tumorigenesis, the role of this pathway in breast cancer bone metastasis is unclear. Dickkopf1 (Dkk1) is a secreted Wnt/β-catenin antagonist. In the present study, we demonstrated that activation of Wnt/β-catenin signaling enhanced Dkk1 expression in breast cancer cells and that Dkk1 overexpression is a frequent event in breast cancer. We also found that human breast cancer cell lines that preferentially form osteolytic bone metastases exhibited increased levels of Wnt/β-catenin signaling and Dkk1 expression. Moreover, we showed that breast cancer cell-produced Dkk1 blocked Wnt3A-induced osteoblastic differentiation and osteoprotegerin (OPG) expression of osteoblast precursor C2C12 cells and that these effects could be neutralized by a specific anti-Dkk1 antibody. In addition, we found that breast cancer cell conditioned media were able to block Wnt3A-induced NF-kappaB ligand reduction in C2C12 cells. Finally, we demonstrated that conditioned media from breast cancer cells in which Dkk1 expression had been silenced via RNAi were unable to block Wnt3A-induced C2C12 osteoblastic differentiation and OPG expression. Taken together, these results suggest that breast cancer-produced Dkk1 may be an important mechanistic link between primary breast tumors and secondary osteolytic bone metastases.

KW - Bone metastasis

KW - Dkk1

KW - OPG

KW - Osteoblast differentiation

KW - Wnt signaling

UR - http://www.scopus.com/inward/record.url?scp=47249149740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249149740&partnerID=8YFLogxK

U2 - 10.1002/ijc.23625

DO - 10.1002/ijc.23625

M3 - Article

VL - 123

SP - 1034

EP - 1042

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -